R
Remedtherapeutics
REMED Therapeutics develops novel therapeutics utilizing its RENALASE platform technology. The company focuses on creating new classes of treatments for acute pancreatitis, associated pain, and acute kidney injury. Their pipeline also targets hard-to-treat cancers with differentiated therapeutic candidates.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- REMED Therapeutics develops novel therapeutics utilizing its RENALASE platform technology. The company focuses on creating new classes of treatments for acute pancreatitis, associated pain, and acute kidney injury. Their pipeline also targets hard-to-treat cancers with differentiated therapeutic candidates.